Dyax

 

Advancing Novel Biotherapeutics Since 1995®

 

Opportunities for growth stem from our established success and valued collaborations.

E-mail Alert Subscription

Step 1 of 3: Select Options

You may automatically receive Dyax Corp. financial information by e-mail. Please enter your preferences for e-mail notifications below and click "Continue" to enter your contact information on the next page. If you have already signed up and would like to review your subscription, click here.

Press Releases

SEC Filings
  
  
  

Webcasts and Events
in advance of any event.

Unsubscribe from Investor Relations e-mail alerts.

Our e-mail alerts provide automated opt-out methods as well as complete contact information.

Print

Print Page

 		E-mail

E-mail Page


May 20, 2013, 4:00 PM ET

Stock quote

Exchange NASDAQ (US Dollars)
Price $2.52
Change (%) 0.02 (-0.79)%
See more

IR TOOL KIT

Investor Relations Contacts

Jennifer Robinson
Associate Director, Investor Relations and Corporate Communications
Dyax Corp.
Phone: 617-225-2500


See All

 

You are now leaving Dyax.com.

The web site you are about to visit is . It is neither owned nor controlled by Dyax Corp. Dyax is not responsible for the content, products or services on this site.

Do you wish to continue?